Back to Search
Start Over
Cardiopulmonary Effects of Enprofylline
- Source :
- Chest. 94:354-359
- Publication Year :
- 1988
- Publisher :
- Elsevier BV, 1988.
-
Abstract
- The acute cardiovascular effects of a new xanthine, enprofylline, were studied in patients with chronic lung disease. The studies were done during cardiac catheterization (n = 12) and by radionuclide ventriculography (n = 6). Enprofylline was given intravenously, 2 mg/kg, and measurements were done after ten and 30 min. Enprofylline reduced the mean pulmonary artery pressure from 30 ± 10 to 26 ± 7 mm Hg (p
- Subjects :
- Pulmonary and Respiratory Medicine
medicine.medical_specialty
Lung
business.industry
medicine.medical_treatment
Radionuclide ventriculography
Critical Care and Intensive Care Medicine
Xanthine
Adenosine receptor
Ventilation/perfusion ratio
chemistry.chemical_compound
medicine.anatomical_structure
chemistry
Internal medicine
Anesthesia
medicine.artery
Pulmonary artery
Cardiology
medicine
Enprofylline
Cardiology and Cardiovascular Medicine
business
Cardiac catheterization
Subjects
Details
- ISSN :
- 00123692
- Volume :
- 94
- Database :
- OpenAIRE
- Journal :
- Chest
- Accession number :
- edsair.doi...........e5e6db49682d9e5623a6e1a0e3182c7b